NCT03280420

Brief Summary

The aim of this work is to compare between early (3days) and late(7days) removal of urinary catheter after acute urine retention in patients with Benign Prostatic Hyperplasia under Tamsulosin treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 12, 2017

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2017

Completed
Last Updated

September 25, 2017

Status Verified

September 1, 2017

Enrollment Period

6 months

First QC Date

August 12, 2017

Last Update Submit

September 20, 2017

Conditions

Keywords

Acute urinary retentionBPHTWOCTamsulosin

Outcome Measures

Primary Outcomes (1)

  • The duration for trial without catheter

    To determine the optimum period to remove catheter in patients complaining of acute urinary retention with benign prostatic hyperplasia.

    6 Months

Secondary Outcomes (1)

  • Factor affecting trial without catheter

    6 Months

Study Arms (2)

early catheter removal

ACTIVE COMPARATOR

30 patients will receive Tamsulosin hydrochloride 0.4 mg once daily and the catheter will be removed after 3 days.

Procedure: Early catheter removal

late catheter removal

ACTIVE COMPARATOR

30 patients will receive Tamsulosin hydrochloride 0.4 mg once daily and the catheter will be removed after 7 days.

Procedure: Late catheter removal

Interventions

Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 3 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy.

Also known as: After 3 days catheter removal
early catheter removal

Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 7 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy.

Also known as: After 7 days catheter removal
late catheter removal

Eligibility Criteria

Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients having first attack of acute urinary retention secondary to BPH.

You may not qualify if:

  • Renal impairment.
  • Suspected urethral stricture.
  • Neurogenic bladder.
  • Cancer prostate.
  • Medically induced retention.
  • Previous use of alpha blockers.
  • History of drug hypersensitivity or allergy to Tamsulosin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine ,Al Azhar university

Cairo, El Mokhayam El Daem St.، Ezbet El-Arab, Nasr City, Cairo, Egypt

Location

Study Officials

  • Mohamed M Badr, PHD

    Al-Azhar University

    STUDY CHAIR
  • Mohamed F El Saeed El Ebiary, MD

    Al-Azhar University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All patients were catheterized and received urinary antiseptic and then randomly divided into two groups : Group I :30 patients received Tamsulosin 0.4 mg once daily and catheter removed after 3 days. Group II :30 patients received Tamsulosin 0.4 mg once daily and catheter removed after 7 days.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Cairo, Egypt

Study Record Dates

First Submitted

August 12, 2017

First Posted

September 12, 2017

Study Start

March 12, 2017

Primary Completion

September 16, 2017

Study Completion

September 16, 2017

Last Updated

September 25, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations